These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25329696)

  • 1. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.
    Li S; Miller CH; Giannopoulou E; Hu X; Ivashkiv LB; Zhao B
    J Clin Invest; 2014 Nov; 124(11):5057-73. PubMed ID: 25329696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
    Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
    J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
    Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
    J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis.
    Kim HS; Kim DK; Kim AR; Mun SH; Lee SK; Kim JH; Kim YM; Choi WS
    Cell Signal; 2012 Jun; 24(6):1306-14. PubMed ID: 22387224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
    Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
    J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
    Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T
    Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency.
    Wu Y; Torchia J; Yao W; Lane NE; Lanier LL; Nakamura MC; Humphrey MB
    PLoS One; 2007 Jul; 2(7):e586. PubMed ID: 17611621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.
    Zhao B
    Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.
    Mao D; Epple H; Uthgenannt B; Novack DV; Faccio R
    J Clin Invest; 2006 Nov; 116(11):2869-79. PubMed ID: 17053833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
    Humphrey MB; Nakamura MC
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insight into osteoclast differentiation in osteoimmunology.
    Takayanagi H
    J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.
    Inoue K; Hu X; Zhao B
    FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
    Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis.
    Choi HK; Kang HR; Jung E; Kim TE; Lin JJ; Lee SY
    Cell Res; 2013 Apr; 23(4):524-36. PubMed ID: 23478294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals.
    Taguchi Y; Gohda J; Koga T; Takayanagi H; Inoue J
    Genes Cells; 2009 Nov; 14(11):1331-45. PubMed ID: 19845770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
    Zawawi MS; Dharmapatni AA; Cantley MD; McHugh KP; Haynes DR; Crotti TN
    Biochem Biophys Res Commun; 2012 Oct; 427(2):404-9. PubMed ID: 23000414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function.
    Humphrey MB; Daws MR; Spusta SC; Niemi EC; Torchia JA; Lanier LL; Seaman WE; Nakamura MC
    J Bone Miner Res; 2006 Feb; 21(2):237-45. PubMed ID: 16418779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBP-J and ITAM crosstalk.
    Zhao B
    Oncotarget; 2015 Nov; 6(34):35135-6. PubMed ID: 26459387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.